The Mini-Mental State Examination (MMSE) is a widely used tool to assess cognitive impairment associated with Alzheimer's Disease and dementia. It consists of a series of questions and tasks that evaluate various cognitive functions such as orientation to time and place, attention and calculation, memory, language, and visuospatial abilities.
In clinical settings, the MMSE helps clinicians track cognitive decline over time, assess the severity of impairment, and aid in diagnosing dementia. It provides a standardized way to measure changes in cognitive function and monitor responses to treatment or interventions.
However, the MMSE has limitations, such as its sensitivity to educational background and cultural differences. Despite these limitations, it remains a valuable tool in the initial evaluation and ongoing management of Alzheimer's Disease and dementia, providing essential insights into the patient's cognitive status and aiding in care planning.
Title : Cerebral vascular calcium signaling in diabetic alzheimer's disease-related dementias
Yong Xiao Wang, Albany Medical College, United States
Title : Deep learning-based risk assessment of cognitive impairment using health examination data
Kaoru Sakatani, The University of Tokyo, Japan
Title : Evaluation of the neuroprotective potential of indicaxanthin from opuntia ficus indica fruit against dysmetabolism-related neurodegeneration both in vivo and in vitro
Mario Allegra, University of Palermo, Italy
Title : Cogs Club: Making a difference
Jacqueline Tuppen, Cogs Club, United Kingdom
Title : Development of imaging based biomarkers for neurovascular abnormalities in neurodegenerative diseases
Jun Hua, Johns Hopkins University School of Medicine, United States
Title : Psychosocial considerations in management of corticobasal degeneration
Esraa Askar, Forest Hills Hospital, United States